In re Vitamins Antitrust Litigation

198 F.R.D. 296, 2000 U.S. Dist. LEXIS 17424, 2000 WL 33142130
District Court, District of Columbia·Decided November 22, 2000·No. Nos. 99-197 TFH, 1285·Published·Cited by 44 cases

Opinion

[297] MEMORANDUM OPINION Re: Downstream Data

THOMAS F. HOGAN, District Judge.

Pending before the Court are defendants’ Rule 53 Objections to the Special Master’s Report recommending denial of defendants’ Joint Motion to Compel the Production of Documents. After carefully considering the Special Master’s Report, the defendants’ objections, the plaintiffs’ response, the defendants’ reply, and the entire record herein, the Court will adopt the Special Master’s Report and Recommendations. Specifically, the Court will deny defendants’ Motion to the extent that it seeks an order compelling production of downstream data, financial data and exchange rate data1. The Court will also grant certain class plaintiffs’ Motion for Voluntary Dismissal Without Prejudice and without costs on the condition that these plaintiffs respond to all previously noticed document requests and interrogatories.

I. BACKGROUND

On May 23, 2000, defendants filed a Joint Motion to Compel the Production of Documents in Response to Certain Defendants’ First Consolidated Set of Requests filed December 20, 1999, as modified by the memorandum from Andrew S. Marovitz to all plaintiffs’ counsel dated April 10, 2000. Defendants sought to discover: (1) documents regarding plaintiffs’ use, manufacture, sale, marketing, distribution or supply of vitamins or vitamin-containing products (“downstream data”); (2) documents regarding plaintiffs’ public and nonpublic financial information (“financial data”); (3) documents relating to currency exchange rates as they relate to any purchase, manufacture, sale or distribution of any vitamin product or vitamin-containing product (“exchange rate data”); and (4) documents from each of the 25 plaintiffs named in the Second Consolidated Amended Class Action Complaint rather than merely from the six plaintiffs designated as class representatives.

These issues were referred to the Special Master, who heard oral argument on all four questions on June 22, 2000. In a written Report dated July 28, 2000, the Special Master concluded that, aside from the dispute about discovery from all named plaintiffs as compared to class representatives, the extreme burden of defendants’ requests outweighed any “marginal relevance” this material might have; the Special Master thus recommended denial of defendants’ Motion to Compel production of downstream, financial, and exchange rate data. The Special Master did, however, recommend granting defendants’ Motion to Compel insofar as defendants sought an order requiring production of discovery from all plaintiffs named in the Second Consolidated Amended Class Action Complaint rather than merely from the six plaintiffs designated as class representatives.

II. STANDARD OF REVIEW

Findings of fact in a Special Master’s report are reviewed for clear error, while conclusions of law are reviewed de novo. See D.M.W. Contracting Co. v. Stolz, 158 F.2d 405, 406-7 (D.C.Cir.1946); Hartman v. Duf[298] fey, 973 F.Supp. 199, 200 (D.D.C.1997); see also Fed.R.Civ.P. 53 (“Masters”).

In this case, the Special Master’s determinations regarding relevance should be reviewed de novo, since the issue of relevance is a legal question. However, the Special Master’s burden versus benefit analysis should be reviewed for “clear error” since it involved factual determinations based on affidavits and evidence properly submitted to the Special Master.2

III. DISCUSSION

A. Downstream Data

Defendants seek an order compelling responses to 29 document requests to the extent that those requests describe documents regarding each plaintiffs use, manufacture, sale, marketing, distribution, or supply of vitamins or vitamin-containing products.3 Defendants argue that they are entitled to this downstream data because it is probative on the issue of damages suffered by direct purchaser plaintiffs.4 Citing statements of plaintiffs’ proposed expert, Dr. John C. Beyer (“Beyer”), defendants assert that individualized plaintiff-by-plaintiff downstream data are relevant to the demand for defendants’ vitamin products because demand is a factor in determining the prices plaintiffs would have been charged “but for” the conspiracy and that the damages recoverable by the direct purchasers will be determined by the difference between the “but for” prices and the prices actually charged pursuant to the conspiracy.

By contrast, plaintiffs cite Hanover Shoe v. United Shoe Machinery Corp., 392 U.S. 481, 489, 88 S.Ct. 2224, 20 L.Ed.2d 1231 (1968) and Illinois Brick Co. v. Illinois, 431 U.S. 720, 745-46, 97 S.Ct. 2061, 52 L.Ed.2d 707 (1977), for the proposition that antitrust defendants cannot avoid liability for overcharges on the ground that plaintiffs were able to pass-on any additional costs, and several district court rulings barring discovery of down-stream data as irrelevant given the unavailability of the pass-on defense. In addition, plaintiffs argue that the first Beyer affidavit refers to industry-wide, publicly-available downstream data and that defendants have not established their need for plaintiff-specific information. Finally, plaintiffs claim that defendants’ requests for individualized downstream data are “unreasonably burdensome and vexatious” and would “encompass thousands of different products sold by plaintiffs, and literally every document relating to the businesses of the plain[299] tiffs selling those products.” See Pl’s 6/7/00 Mem. at 9. Defendants respond that Hanover Shoe and Illinois Brick have no applicability to this issue because defendants are not seeking this downstream data in order to assert a pass-on defense. Defendants also contend that plaintiffs have not met their burden of showing how these requests are overly burdensome or oppressive.

Free access — add to your briefcase to read the full text and ask questions with AI

In re Vitamins Antitrust Litigation, 198 F.R.D. 296, 2000 U.S. Dist. LEXIS 17424, 2000 WL 33142130 (D.D.C. 2000).

198 F.R.D. 296 (In re Vitamins Antitrust Litigation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Rodriguez v. Google LLC
N.D. California, 2025
White v. Contee
District of Columbia, 2022
Wildearth Guardians v. Jewell
District of Columbia, 2022
Wildearth Guardians v. Bernhardt
District of Columbia, 2022
Bell v. Department of Defense
District of Columbia, 2018
Mitchell v. U.S. Bank Nat'l Ass'n
293 F. Supp. 3d 209 (D.C. Circuit, 2018)
N.S. Ex Rel. S.S. v. District of Columbia
272 F. Supp. 3d 192 (District of Columbia, 2017)
Queen v. Schmidt
District of Columbia, 2016
Musgrove v. Brookings Institution
District of Columbia, 2015
Guttenberg v. Emery
68 F. Supp. 3d 184 (District of Columbia, 2014)
In re Photochromic Lens Antitrust Litigation
279 F.R.D. 620 (M.D. Florida, 2012)
Busby v. Capital One, N.A.
841 F. Supp. 2d 49 (District of Columbia, 2012)
Mittakarin v. Infotran Systems, Inc.
279 F.R.D. 38 (District of Columbia, 2012)